<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00596986</url>
  </required_header>
  <id_info>
    <org_study_id>EUK-B2.1</org_study_id>
    <secondary_id>EUK-B2</secondary_id>
    <nct_id>NCT00596986</nct_id>
  </id_info>
  <brief_title>Getting Biased Treatment Study: How Psychotherapy and Antidepressants Change Brain Activity in Chronic Depression</brief_title>
  <acronym>GETTY</acronym>
  <official_title>Impact of Therapeutical Strategies on Emotional Processing in Depression: Neurofunctional and Clinical Issues in the Context of Affective Bias</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Federal Ministry of Education and Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine how psychotherapy and pharmacotherapy respectively
      change brain activity in patients suffering from chronic depression.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>October 2008</start_date>
  <primary_completion_date type="Anticipated">September 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neuroimaging Data (fMRI)</measure>
    <time_frame>Before and After Therapy</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>HAMD</measure>
    <time_frame>Weekly</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Salivary Cortisol</measure>
    <time_frame>Before and After Therapy</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Chronic Depression</condition>
  <arm_group>
    <arm_group_label>AD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Antidepressant Duloxetine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Psychotherapy (CBASP) - Cognitive Behavioural Analysis System of Psychotherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Duloxetine</intervention_name>
    <description>Duloxetine 30mg up to 120mg per day.</description>
    <arm_group_label>AD</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavioural Analysis System of Psychotherapy</intervention_name>
    <description>Cognitive Behavioural Analysis System of Psychotherapy (CBASP): 20 sessions of psychotherapy, beginning with twice weekly, then weekly sessions.</description>
    <arm_group_label>PT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic Depression (Double Depression, Chronic MDE, MDE with incomplete remission)

          -  HAMD-24&gt;20

        Exclusion Criteria:

          -  Concurrent Psychotherapy or Psychopharmacotherapy

          -  Previous Non-Response to Duloxetine

          -  Non-Response to three Antidepressants of two different groups given at adequate doses
             or Non-Response to two empirically tested forms of Psychotherapy in the current
             Depressive Episode

          -  Serious Psychiatric comorbidity

          -  Serious Neurologic comorbidity

          -  Contraindications to Duloxetine

          -  Contraindications to fMRI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Isabella Heuser, Prof. Dr. med. Dipl. Psych.</last_name>
    <role>Study Chair</role>
    <affiliation>Dept. of Psychiatry, Campus Benjamin Franklin, Charité Berlin, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Colla, Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Psychiatry, Campus Benjamin Franklin, Charité Berlin, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Charité Universitätsmedizin</name>
      <address>
        <city>Berlin</city>
        <zip>14050</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 8, 2008</study_first_submitted>
  <study_first_submitted_qc>January 8, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 17, 2008</study_first_posted>
  <last_update_submitted>July 31, 2009</last_update_submitted>
  <last_update_submitted_qc>July 31, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 3, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr. med. Michael Colla</name_title>
    <organization>Dept. of Psychiatry, Campus Benjamin Franklin, Charite University, Berlin, Germany</organization>
  </responsible_party>
  <keyword>Depression</keyword>
  <keyword>Duloxetine</keyword>
  <keyword>Psychotherapy</keyword>
  <keyword>Magnetic Resonance Imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antidepressive Agents</mesh_term>
    <mesh_term>Duloxetine Hydrochloride</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

